Texas Instruments director exercises 4,306 options

Q: How many TXN shares did director Janet F. Clark sell, and at what prices?

Janet F. Clark sold 3,956 shares at a weighted average of $302.40 per share and 350 shares at a weighted average of $303.17 per share on October 27, 2026. The disclosed price ranges were $302.11 to $303.01 and $303.13 to $303.24, respectively; no Rule 10b5-1 plan is reported.

Q: What were the vesting and expiration terms of Janet F. Clark's TXN options?

The options became exercisable in four equal annual installments beginning January 25, 2019, and had an expiration date of January 25, 2028.

The exercise was paired with two separately reported sale blocks, and the reported option position afterward was zero.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Texas Instruments Inc. (TXN) director Janet F. Clark exercised 4,306 NQ stock options on October 27, 2026, at an exercise price of $110.15 per share, acquiring 4,306 common shares. That day, she sold 3,956 shares at a weighted average of $302.40 per share and 350 shares at a weighted average of $303.17 per share. The reported option position following the exercise was zero, and no Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 4,306 shares ($828K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider CLARK JANET F

Role Director

Sold 4,306 shs ($1.30M)

Approx. gross sale proceeds $1.30M

Approx. exercise cost $474K

Approx. pre-tax spread $828K

Type	Security	Shares	Price	Value
Exercise	NQ Stock Option (Right to Buy) ^F3	4,306	$0.00	$0.00
Exercise	Common Stock	4,306	$110.15	$474K
Sale	Common Stock ^F1	3,956	$302.40	$1.20M
Sale	Common Stock ^F2	350	$303.17	$106K

Holdings After Transaction: NQ Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 11,341 shares (Direct)

Footnotes (3)

F1. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F2. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
F3. The option became exercisable in four equal annual installments beginning on January 25, 2019.

Key Figures

NQ stock options exercised: 4,306 options Exercise price: $110.15 per share Common shares acquired: 4,306 shares +4 more

7 metrics

NQ stock options exercised 4,306 options October 27, 2026

Exercise price $110.15 per share Options exercised October 27, 2026

Common shares acquired 4,306 shares October 27, 2026

Shares sold 3,956 shares October 27, 2026

Weighted average sale price $302.40 per share Sale of 3,956 shares on October 27, 2026

Shares sold 350 shares October 27, 2026

Weighted average sale price $303.17 per share Sale of 350 shares on October 27, 2026

Key Terms

NQ Stock Option (Right to Buy), weighted average sale price, exercise price, four equal annual installments

4 terms

NQ Stock Option (Right to Buy) technical

"NQ Stock Option (Right to Buy)"

weighted average sale price financial

"The price in Table 1 is a weighted average sale price"

exercise price financial

"at an exercise price of $110.15 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

four equal annual installments technical

"in four equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TXN shares did director Janet F. Clark sell, and at what prices?

Janet F. Clark sold 3,956 shares at a weighted average of $302.40 per share and 350 shares at a weighted average of $303.17 per share on October 27, 2026. The disclosed price ranges were $302.11 to $303.01 and $303.13 to $303.24, respectively; no Rule 10b5-1 plan is reported.

What were the vesting and expiration terms of Janet F. Clark's TXN options?

The options became exercisable in four equal annual installments beginning January 25, 2019, and had an expiration date of January 25, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/29/2026 - 04:35 PM EDT Accepted by SEC EDGAR 10/29/2026 - 04:35 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CLARK JANET F

(Last)

(First)

(Middle)

12500 TI BOULEVARD

(Street)

DALLAS

TEXAS

75243

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEXAS INSTRUMENTS INC [ TXN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/27/2026		M		4,306	A	$110.15	15,647	D
Common Stock	10/27/2026		S		3,956	D	$302.4⁽¹⁾	11,691	D
Common Stock	10/27/2026		S		350	D	$303.17⁽²⁾	11,341	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
NQ Stock Option (Right to Buy)	$110.15	10/27/2026		M			4,306	⁽³⁾	01/25/2028	Common Stock	4,306	$0	0	D

Explanation of Responses:

1. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $302.11 to $303.01. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

2. The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $303.13 to $303.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.

3. The option became exercisable in four equal annual installments beginning on January 25, 2019.

Remarks:

	/s/ John Whitney, Attorney in Fact	10/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR